Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study.

Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, Kramer HJ, Spengler U, Schild H, Sauerbruch T.

Gut. 2000 Aug;47(2):288-95.

2.

Review article: prognosis of hepatorenal syndrome--has it changed with current practice?

Angeli P.

Aliment Pharmacol Ther. 2004 Sep;20 Suppl 3:44-6; discussion 47-8. Review.

3.

TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?

Gülberg V, Gerbes AL.

Z Gastroenterol. 2002 Sep;40(9):823-6. Review.

PMID:
12215953
4.

The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.

Colombato L.

J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S344-51. Review.

PMID:
17975487
5.

[Hepatorenal syndrome].

Radziszewski A, Sułowicz W.

Przegl Lek. 2006;63(7):573-8. Review. Polish.

PMID:
17203812
6.

Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.

Senzolo M, Cholongitas E, Tibballs J, Burroughs A, Patch D.

Eur J Gastroenterol Hepatol. 2006 Nov;18(11):1143-50. Review.

PMID:
17033432
7.

Hepatorenal syndrome.

Guevara M, Rodés J.

Int J Biochem Cell Biol. 2005 Jan;37(1):22-6. Review.

PMID:
15381144
8.

The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.

Garcia-Tsao G.

Nat Clin Pract Gastroenterol Hepatol. 2006 Jul;3(7):380-9. Review.

PMID:
16819501
9.

Hepatorenal syndrome.

Bataller R, Ginès P, Arroyo V, Rodés J.

Clin Liver Dis. 2000 May;4(2):487-507. Review.

PMID:
11232202
10.

Transjugular intrahepatic portosystemic shunt for refractory ascites: an analysis of the literature on efficacy, morbidity, and mortality.

Russo MW, Sood A, Jacobson IM, Brown RS Jr.

Am J Gastroenterol. 2003 Nov;98(11):2521-7. Review.

PMID:
14638358
11.

Hepatorenal syndrome: do the vasoconstrictors work?

Leung W, Wong F.

Gastroenterol Clin North Am. 2011 Sep;40(3):581-98. doi: 10.1016/j.gtc.2011.06.011. Review. Erratum in: Gastroenterol Clin North Am. 2011 Dec;40(4):XV.

PMID:
21893275
12.

[Hepatorenal syndrome].

Huschak G, Kaisers UX, Laudi S.

Anaesthesist. 2013 Jul;62(7):571-82. doi: 10.1007/s00101-013-2197-3. Review. German.

PMID:
23846211
13.

Hepatorenal syndrome.

Bataller R, Arroyo V, Ginès P, Sort P.

Forum (Genova). 1998 Jan-Mar;8(1):62-81. Review.

PMID:
9565447
14.

Hepatorenal syndrome: a review.

Testino G, Ferro C.

Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1279-84. Review.

PMID:
21410072
15.

TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis.

Bai M, Qi XS, Yang ZP, Yang M, Fan DM, Han GH.

World J Gastroenterol. 2014 Mar 14;20(10):2704-14. doi: 10.3748/wjg.v20.i10.2704. Review.

16.

Management of hepatorenal syndrome in patients with cirrhosis.

Arroyo V, Fernández J.

Nat Rev Nephrol. 2011 Aug 9;7(9):517-26. doi: 10.1038/nrneph.2011.96. Review.

PMID:
21826080
17.

Hepatorenal syndrome.

Guevara M, Ginès P.

Dig Dis. 2005;23(1):47-55. Review.

PMID:
15920325
18.

Hepatorenal syndrome.

Ginès P, Guevara M, Arroyo V, Rodés J.

Lancet. 2003 Nov 29;362(9398):1819-27. Review.

PMID:
14654322
19.

Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials.

Sagi SV, Mittal S, Kasturi KS, Sood GK.

J Gastroenterol Hepatol. 2010 May;25(5):880-5. doi: 10.1111/j.1440-1746.2009.06132.x. Epub 2010 Jan 14. Review.

PMID:
20074149
20.

[Hepatorenal syndrome].

Pŭrvanov P.

Khirurgiia (Sofiia). 2002;58(2):34-9. Review. Bulgarian.

PMID:
12515019

Supplemental Content

Support Center